Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status updated to not currently enrolling participants. The record's revision tag was updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page history now reflects a new revision label (v3.5.5) replacing the previous v3.5.4, indicating an updated version of the record.SummaryDifference0.0%

- Check42 days agoChange DetectedA new history entry dated 2026-05-08 adds a Study Status update and Revision: v3.5.4 to the record history. The prior Revision: v3.5.3 entry from 2026-04-13 has been removed.SummaryDifference0.2%

- Check56 days agoChange DetectedA new revision entry (v3.5.3) has been added to the record history, and the previous revision (v3.5.2) has been removed, updating the historical record for the study.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the 2026-04-13 revision (v3.5.2). Deleted the 2026-03-16 revision (v3.5.0).SummaryDifference0.2%

- Check92 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study record history.SummaryDifference0.0%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.